Trial Site Detail

 

Drug:
Imatinib + Sunitinib + Regorafenib
Trial:
Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Oslo University Hospital

     
Oslo , 0424
Norway

 

Principal Investigator:
Mona-Elisabeth Revheim, MD
Contact:
+4723070840 mona.elisabeth.revheim@ous-hf.no
Activation Status of this Site:
Closed
Notes about this Site:
Oslo University Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.